Electrochemical immunomagnetic assay for interleukin-6 detection in human plasma

Grace Buckey1, Olivia E Owens1, Hannah A Richards1

  • 1Department of Chemistry, Vanderbilt University 7330 Stevenson Center, VU Station B351822 Nashville TN 37235-1822 USA d.cliffel@vanderbilt.edu.

Sensors & Diagnostics
|June 17, 2024
PubMed

Insights

A new electrochemical immunoassay for interleukin-6 (IL-6) enables rapid detection in biological samples. This assay shows promise for real-time point-of-care diagnostics.

Area of Science:

  • Biomedical Engineering
  • Analytical Chemistry
  • Immunotechnology

Background:

  • Interleukin-6 (IL-6) is a key cytokine in inflammatory and immune responses.
  • Accurate and rapid IL-6 quantification is crucial for diagnosing various diseases.
  • Existing detection methods can be time-consuming or require specialized equipment.

Purpose of the Study:

  • To develop a sensitive electrochemical immunoassay for detecting interleukin-6 (IL-6).
  • To validate the assay's performance in different biological matrices.
  • To assess the potential for point-of-care applications.

Main Methods:

  • Development of a sandwich immunoassay utilizing magnetic beads for IL-6 capture.
  • Electrochemical signal generation via horseradish peroxidase/tetramethylbenzidine (TMB) enzymatic reaction.
  • Assay validation in phosphate-buffered solution, cell culture media, and spiked human plasma.

Main Results:

  • Achieved sensitive IL-6 detection within the physiologically relevant range of 50-1000 pg mL-1.
  • Demonstrated robust assay performance across various biological samples.
  • Reduced IL-6 concentration readout time to approximately one hour.

Conclusions:

  • The developed electrochemical immunoassay provides a rapid and sensitive method for IL-6 detection.
  • The assay is suitable for use in diverse biological samples, including human plasma.
  • This technology holds significant potential for real-time point-of-care disease diagnostics.